Niagen Bioscience, Inc. (NAGE) vs Zentalis Pharmaceuticals, Inc. (ZNTL)
- Niagen Bioscience, Inc. NAGE 2.49 −3.49%
- Zentalis Pharmaceuticals, Inc. ZNTL 2.13 −4.91%
Niagen Bioscience, Inc. and Zentalis Pharmaceuticals, Inc. are both Biotechnology companies. Niagen Bioscience, Inc. and Zentalis Pharmaceuticals, Inc. are of similar size ($212.1M and $204.2M). Zentalis Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Niagen Bioscience, Inc. trades at 12.5×. Niagen Bioscience, Inc. has the higher net margin (12.4% vs 0.00%) and the higher return on invested capital (42.0% vs 0.00%). Across the 14 metrics below, Niagen Bioscience, Inc. leads on 12 and Zentalis Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | NAGE | ZNTL | Biotechnology median |
|---|---|---|---|
| Gross margin | 64.24% | 0.00% | 65.16% |
| Operating margin | 8.21% | 0.00% | 0.00% |
| Net margin | 12.39% | 0.00% | 0.00% |
| Free cash flow margin | 8.89% | 0.00% | 0.00% |
| Return on equity | 21.80% | (66.75%) | (56.36%) |
| Return on assets | 16.14% | (49.22%) | (48.04%) |
| Return on invested capital | 41.95% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack